159 related articles for article (PubMed ID: 20466298)
1. Ifosfamide-induced encephalopathy in patients with uterine sarcoma.
Liu YL; Tsai SH; Chang FW; Yu MH
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):77-80. PubMed ID: 20466298
[TBL] [Abstract][Full Text] [Related]
2. Role of thiamine in managing ifosfamide-induced encephalopathy.
Hamadani M; Awan F
J Oncol Pharm Pract; 2006 Dec; 12(4):237-9. PubMed ID: 17156595
[TBL] [Abstract][Full Text] [Related]
3. [Ifosfamide induced encephalopathy: 15 observations].
Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide neurotoxicty in a young female with a remarkable response to thiamine.
Imtiaz S; Muzaffar N
J Pak Med Assoc; 2010 Oct; 60(10):867-9. PubMed ID: 21381624
[TBL] [Abstract][Full Text] [Related]
5. Methylene blue for management of Ifosfamide-induced encephalopathy.
Patel PN
Ann Pharmacother; 2006 Feb; 40(2):299-303. PubMed ID: 16391008
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature.
Brunello A; Basso U; Rossi E; Stefani M; Ghiotto C; Marino D; Crivellari G; Monfardini S
Drugs Aging; 2007; 24(11):967-73. PubMed ID: 17953463
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide encephalopathy and use of methylene blue. A case report of different sequential neurotoxicity.
Giovanis P; Garna A; Marcante M; Nardi K; Giusto M
Tumori; 2009; 95(4):545-6. PubMed ID: 19856674
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M
Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
[TBL] [Abstract][Full Text] [Related]
9. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
Pelgrims J; De Vos F; Van den Brande J; Schrijvers D; Prové A; Vermorken JB
Br J Cancer; 2000 Jan; 82(2):291-4. PubMed ID: 10646879
[TBL] [Abstract][Full Text] [Related]
10. High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.
Yalcin B; Pamir A; Buyukcelik A; Utkan G; Akbulut H; Demirkazik A; Icli F
Exp Oncol; 2004 Dec; 26(4):320-5. PubMed ID: 15627067
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide neuropsychiatric toxicity in patients with cancer.
Alici-Evcimen Y; Breitbart WS
Psychooncology; 2007 Oct; 16(10):956-60. PubMed ID: 17278152
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity.
Richards A; Marshall H; McQuary A
J Oncol Pharm Pract; 2011 Dec; 17(4):372-80. PubMed ID: 20861178
[TBL] [Abstract][Full Text] [Related]
13. Important role of thiamine in preventing ifosfamide-induced encephalopathy.
Lombardi G; Zustovich F; Nicoletto MO; Donach M; Pastorelli D
J Oncol Pharm Pract; 2010 Jun; 16(2):135-6. PubMed ID: 19692431
[No Abstract] [Full Text] [Related]
14. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG
Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636
[TBL] [Abstract][Full Text] [Related]
15. Methylene blue for the treatment and prophylaxis of ifosfamide-induced encephalopathy.
Turner AR; Duong CD; Good DJ
Clin Oncol (R Coll Radiol); 2003 Oct; 15(7):435-9. PubMed ID: 14570094
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant.
Howell JE; Szabatura AH; Hatfield Seung A; Nesbit SA
J Oncol Pharm Pract; 2008 Sep; 14(3):157-62. PubMed ID: 18719071
[TBL] [Abstract][Full Text] [Related]
17. [Sequential course and prospective management of ifosfamide-induced multi-organ toxicity].
Mollenkopf A; du Bois A; Meerpohl HG
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):525-8. PubMed ID: 9036065
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of ifosfamide neurotoxicity with dexmedetomidine.
Bernard PA; McCabe T; Bayliff S; Hayes D
J Oncol Pharm Pract; 2010 Dec; 16(4):262-5. PubMed ID: 20118215
[TBL] [Abstract][Full Text] [Related]
19. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL
Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide-induced Encephalopathy With Rapid Response to Thiamine: A Pediatric Case.
Müngen E; Yaman Bajin İ; Öz S; Günbey C; Anlar B; Aydin B
J Pediatr Hematol Oncol; 2022 Oct; 44(7):402-404. PubMed ID: 35536996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
